Genoil (GNOLF) Operating Income (2020 - 2025)
Historic Operating Income for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to -$147005.0.
- Genoil's Operating Income fell 561.69% to -$147005.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 2719.88%. This contributed to the annual value of -$2.0 million for FY2024, which is 4504.97% up from last year.
- According to the latest figures from Q3 2025, Genoil's Operating Income is -$147005.0, which was down 561.69% from -$213951.0 recorded in Q2 2025.
- Over the past 5 years, Genoil's Operating Income peaked at -$104359.0 during Q4 2021, and registered a low of -$2.2 million during Q1 2023.
- In the last 5 years, Genoil's Operating Income had a median value of -$161020.0 in 2021 and averaged -$476844.9.
- As far as peak fluctuations go, Genoil's Operating Income soared by 9633.31% in 2021, and later tumbled by 71164.0% in 2023.
- Genoil's Operating Income (Quarter) stood at -$104359.0 in 2021, then tumbled by 36.84% to -$142801.0 in 2022, then tumbled by 711.64% to -$1.2 million in 2023, then tumbled by 33.71% to -$1.5 million in 2024, then skyrocketed by 90.51% to -$147005.0 in 2025.
- Its Operating Income stands at -$147005.0 for Q3 2025, versus -$213951.0 for Q2 2025 and -$147506.0 for Q1 2025.